Back to Journals » OncoTargets and Therapy » Volume 10
Review
Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
17,949 | Dovepress* | 12,710+ | 1,745 | 14,455 | |
PubMed Central* | 5,239 | 1,026 | 6,265 | ||
Totals | 17,949 | 2,771 | 20,720 | ||
*Since 19 June 2017 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
5 | 0 | 0 | 0 | 0 | 5 |
View citations on PubMed Central and Google Scholar